Abstract：
JRS COPD guideline Edition 4 updated current concept for clinical management of COPD in Japan. Minor but substantial changes were added to the definition and subtype of the disease. In pharmacological treatment, single use of LAMA or LABA is equally the first choice. If it is not enough, those combination are recommended. A-D classification that was presented in GOLD report 2011 was not adopted. In non-pharmacological treatment, pulmonary rehabilitation is steadily effective and essential. In terms of survival prognosis, at least, the concept of physical activity is important. Those improvement and maintenance were newly added to the objectives of the clinical management of COPD.
摘要：
JRSCOPD指南第4版更新了日本COPD临床管理的当前概念。该疾病的定义和亚型增加了微小但实质性的变化。在药物治疗中，单次使用LAMA或LABA同样是首选。如果还不够,这些组合是推荐的。未采用2011年GOLD报告中提出的A-D分类。在非药物治疗中，肺康复是稳定有效和必要的。就生存预后而言，至少,体育活动的概念很重要。这些改善和维持是COPD临床管理目标的新补充。
